Last updated: November 8, 2023
Sponsor: Shape Memory Medical, Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
IMPEDE, IMPEDE-FX or IMPEDE-FX RapidFill
Clinical Study ID
NCT04044443
CRD1012
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Study participant is ≥18 years of age
- Study participant is considered a candidate for arterial or venous embolization of theperipheral vasculature
Exclusion
Exclusion Criteria:
- Study participant has an inability to provide written informed consent
- Study participant/treatment outside of the approved study device labeling,instructions for use (IFU)
- Study participant is a prisoner or member of other vulnerable population
Study Design
Total Participants: 125
Treatment Group(s): 1
Primary Treatment: IMPEDE, IMPEDE-FX or IMPEDE-FX RapidFill
Phase:
Study Start date:
July 09, 2019
Estimated Completion Date:
June 30, 2025
Connect with a study center
Universitätsklinikum Carl-Gustav-Carus an der Technischen Universität Dresden
Dresden, 01307
GermanySite Not Available
Universitätsklinikum Heidelberg
Heidelberg, 69120
GermanyActive - Recruiting
Universitätsklinikum Schleswig-Holstein (Campus Kiel)
Kiel, 24105
GermanyActive - Recruiting
UNIVERSITÄTSKLINIKUM LEIPZIG AöR
Leipzig, 04103
GermanyActive - Recruiting
Klinikum München rechts der Isar
München, 81675
GermanyActive - Recruiting
Klinikum Nürnberg
Nürnberg, 90471
GermanyActive - Recruiting
Klinikum StuttGart
Stuttgart, 70174
GermanyActive - Recruiting
Uniklinikum Würzburg
Würzburg, 97080
GermanyActive - Recruiting
St George's Hospital (St George's University Hospitals NHS Foundation Trust)
London,
United KingdomActive - Recruiting
St Mary's Hospital (Imperial College Healthcare NHS Trust)
London,
United KingdomActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.